IPP Bureau
Panchsheel Organics to set up fermentation/API unit
By IPP Bureau - November 27, 2022
Total investment envisaged in this project stands at up to Rs 70 crore
Briefs: IOL Chemicals and Cipla
By IPP Bureau - November 27, 2022
Government of India has granted a patent for invention entitled "An improved safe process for the preparation of Sartan drugs of Formula I".
Delivery solution provider ZIM Laboratories Limited lists on NSE
By IPP Bureau - November 26, 2022
The total quantity traded at NSE stood at 34,653 shares and the total turnover stood at Rs. 117.23 lakh.
AstraZeneca receives import and market permission from CDSCO for Dapagliflozin
By IPP Bureau - November 26, 2022
The receipt of this permission paves way for the launch of Dapagliflozin (Forxiga) tablets of 10 mg in India for the specified additional/expanded indication, subject to the receipt of related statutory approvals
Ministry of Ayush and DST sign MoU to identify areas of research
By IPP Bureau - November 26, 2022
The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products
CPHI Frankfurt 2022: Global pharma confidence hits record high in CPHI Pharma Index
By IPP Bureau - November 26, 2022
In fact, the overall CPHI Pharma Index – a collateralised metric of all major ranking categories – has risen by more than 8%, the largest year-on-year gain in the survey’s six year history
India’s plan for containment of AMR focuses on an integrated One Health approach: Dr. Bharti
By IPP Bureau - November 26, 2022
It serves to leverage the strengths of various institutions to coordinate AMR surveillance lab networks
USFDA inspects Lupin's Mandideep Unit-1 facility
By IPP Bureau - November 25, 2022
The inspection of the facility resulted in issuance of a Form-483 with eight observations each for the Drug Product facility and API facility at the site
Laurus Labs takes stake in Ethan Energy India
By IPP Bureau - November 25, 2022
This will enable the company to consume 100% of the solar energy to be supplied by Ethan Energy India Private Limited from their 10 MW Solar Energy plant
Neuland Laboratories appoints Abhijit Majumdar as CFO
By IPP Bureau - November 24, 2022
He brings over 30 years of experience across various organizations such as Asian Paints PPG, Berger Paints, Tata Steel, among others
USFDA issues warning letter to Glenmark's Goa manufacturing facility
By IPP Bureau - November 24, 2022
The company does not believe that the warning letter will have an impact on disruption of supplies or the existing revenues from operations of this facility
Biocon enters commercialization agreement with Zentiva
By IPP Bureau - November 24, 2022
Under the terms of this agreement Biocon will be responsible for the manufacturing and supply of Liraglutide to Zentiva, for its commercialization across 30 countries in Europe
Zydus receives final approval from USFDA for Famotidine Injection
By IPP Bureau - November 24, 2022
Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed
Evive enters license agreement with Acrotech Biopharma to commercialize Ryzneuta in US
By IPP Bureau - November 24, 2022
Ryzneuta is a novel dimeric G- CSF long-acting fusion protein without pegylation. The Biologics License Application (BLA) of Ryzneuta is currently under late-stage review by the US FDA for Chemotherapy-Induced Neutropenia (CIN)
BHL announces inauguration of Opium Processing Business at Savli
By IPP Bureau - November 24, 2022
The new production line is equipped with the latest advanced manufacturing system to produce quality products of Alkaloids & APIs used in a wide range of pharmaceutical applications
